ABVX logo

ABIVAX SA (ABVX)

Profile

Full Name

ABIVAX Société Anonyme

Ticker Symbol

ABVX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

France

IPO

October 20, 2023

Indexes

Not included

Website

http://www.abivax.com

Employees

69

Key Details

Price

$7.76(+1.31%)

Market cap

$492.40M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.03(+18.39% YoY)

PE ratio

-

Next earnings date

Aug 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.76
    ABVX price is $7.76

    30-Day Relative Volume

    0.68
    ABVX 30-day relative volume is 0.68

    Price Performance

    Price Most recent change

    +1.31%
    ABVX price was up +1.31% on Jul 2, 2025

    Price YTD change

    +6.01%
    ABVX price is up +6.01% since January 1st

    Price 1-year change

    -42.52%
    ABVX price is down -42.52% year-on-year

    Price 3-year change

    -
    ABVX price 3-year change is unknown

    Price Range

    Price All-time high

    $17.02
    ABVX price is currently -54.41% below its historical high of $17.02

    Price 3-year low

    $4.77
    ABVX price is currently +62.68% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $492.40M
    ABVX market capitalization is $492.40 million

    Market cap 3-year change

    -
    ABVX market capitalization 3-year change is unknown

    Market cap All-time high

    $999.76M
    ABVX market capitalization is currently -50.75% below its historical high of $999.76 million

    Market cap sector rank

    66.69%
    ABVX market capitalization is higher than 66.69% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.85%
    ABVX shares outstanding is up +0.85% year-on-year

    Shares Outstanding 3-Year Change

    +278.3%
    ABVX shares outstanding is up +278.3% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.06
    ABVX beta is 1.06

    200-day SMA

    $7.76
    ABVX price is currently +0.03% above its 200-day simple moving average

    50-day SMA

    $6.75
    ABVX price is currently +14.90% above its 50-day simple moving average

    RSI

    63.46
    ABVX 14-day relative strength index is 63.46

    Volume

    0.68
    ABVX 30-day relative volume is 0.68

    ATR

    $0.47
    ABVX average true range is $0.47

    10-day Historical Volatility

    48.17%
    ABVX 10-day historical volatility is 48.17%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    ABVX annual revenue value is unknown

    Revenue Analysts estimate

    $7.24M
    ABVX annual revenue is currently equal to the consensus analysts' forecast

    Revenue 1-year change

    -
    ABVX annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    ABVX annual revenue is unknown

    EPS

    EPS

    -$3.03
    ABVX annual earnings per share is -$3.03

    EPS Analysts estimate

    -$3.25
    ABVX annual earnings per share is currently -6.86% lower than the consensus analysts' forecast

    EPS 1-year change

    +18.39%
    ABVX annual earnings per share is up +18.39% year-on-year

    EPS Sector rank

    29.24%
    ABVX annual earnings per share is higher than 29.24% of companies in Healthcare sector

    Profit

    Gross profit

    -
    ABVX annual gross profit value is unknown

    Gross margin

    -
    ABVX annual gross profit margin value is unknown

    Operating profit

    -$187.23M
    ABVX annual operating income is -$187.23 million

    Operating margin

    -
    ABVX annual operating profit margin value is unknown

    Net income

    -$190.76M
    ABVX annual net profit is -$190.76 million

    Net margin

    -
    ABVX annual net profit margin value is unknown

    Expenses

    Total expenses

    $187.23M
    ABVX annual total expenses is $187.23 million

    Operating expenses

    $187.23M
    ABVX annual total operating expenses is $187.23 million

    Cost of goods sold

    -
    ABVX annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $42.10M
    ABVX annual SGA is $42.10 million

    Depreciation and amortization

    $1.19M
    ABVX annual depreciation & amortization is $1.19 million

    Interest expense

    $13.45M
    ABVX annual interest expense is $13.45 million

    Income tax

    $0.00
    ABVX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$177.30M
    ABVX annual earnings before interest & taxes is -$177.30 million

    EBITDA

    -$176.11M
    ABVX annual EBITDA is -$176.11 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $213.55M
    ABVX annual total assets is $213.55 million

    Non current assets

    $35.96M
    ABVX annual long term assets is $35.96 million

    Current assets

    $177.60M
    ABVX annual total current assets is $177.60 million

    Cash and cash equivalents

    $150.07M
    ABVX annual cash & cash equivalents is $150.07 million

    Accounts receivable

    -
    ABVX annual accounts receivable value is unknown

    Inventory

    -
    ABVX annual inventory value is unknown

    Liabilities

    Total liabilities

    $171.32M
    ABVX annual total liabilities is $171.32 million

    Long term liabilities

    $74.72M
    ABVX annual total long term liabilities is $74.72 million

    Current liabilities

    $96.60M
    ABVX annual total current liabilities is $96.60 million

    Accounts payable

    $45.60M
    ABVX annual accounts payable is $45.60 million

    Debt

    Total debt

    $101.31M
    ABVX annual total debt is $101.31 million

    Total debt 1-year change

    +57.9%
    ABVX annual total debt is up +57.9% year-on-year

    Long term debt

    $55.77M
    ABVX annual long term debt is $55.77 million

    Short term debt

    $45.54M
    ABVX annual short term debt is $45.54 million

    Equity & Capital

    Shareholders equity

    $42.23M
    ABVX annual stockholders equity is $42.23 million

    Book value

    $42.23M
    ABVX annual book value is $42.23 million

    Retained earnings

    -$456.68M
    ABVX annual retained earnings is -$456.68 million

    Working capital

    $80.99M
    ABVX annual working capital is $80.99 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$166.76M
    ABVX annual cash flow from operations is -$166.76 million

    Cash from operations 1-year change

    -58.59%
    ABVX annual cash flow from operations is down -58.59% year-on-year

    Cash from investing

    $17.06M
    ABVX annual cash flow from investing activities is $17.06 million

    Cash from investing 1-year change

    +294.67%
    ABVX annual cash flow from investing activities is up +294.67% year-on-year

    Cash from financing

    $30.53M
    ABVX annual cash flow from financing activities is $30.53 million

    Cash from financing 1-year change

    -91.59%
    ABVX annual cash flow from financing activities is down -91.59% year-on-year

    CAPEX

    CAPEX

    -
    ABVX annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    ABVX annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$167.46M
    ABVX annual free cash flow is -$167.46 million

    Free cash flow 1-year change

    -58.82%
    ABVX annual free cash flow is down -58.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ABVX annual gross profit margin value is unknown

    Operating margin

    -
    ABVX annual operating profit margin value is unknown

    Net margin

    -
    ABVX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -89.32%
    ABVX annual return on assets is -89.32%

    ROE

    -451.70%
    ABVX annual return on equity is -451.70%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ABVX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ABVX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -69.00
    ABVX price to book ratio is -69.00

    PB ratio Sector rank

    0.41%
    ABVX price to book ratio is higher than 0.41% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ABVX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ABVX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $480.48M
    ABVX enterprise value is $480.48 million

    Enterprise value Sector rank

    66.09%
    ABVX enterprise value is higher than 66.09% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -9.60
    ABVX EV/EBITDA is -9.60

    EV/EBITDA Sector rank

    14.2%
    ABVX EV/EBITDA is higher than 14.2% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.84
    ABVX annual current ratio is 1.84

    Quick ratio

    -
    ABVX annual quick ratio value is unknown

    Leverage

    Debt to equity

    2.40
    ABVX annual debt to equity ratio is 2.40

    Interest coverage ratio

    -13.18
    ABVX annual interest coverage ratio is -13.18

    Risk & Stability

    Piotroski F-Score

    -
    ABVX piotroski f-score value is unknown

    Altman Z-Score

    -
    ABVX altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Apr 30, 25 JMP Securities
    Market Outperform
    Mar 18, 25 Citizens Capital Markets
    Market Outperform
    Jan 10, 25 JMP Securities
    Market Outperform
    Dec 4, 24 JMP Securities
    Market Outperform
    Jul 29, 24 Laidlaw & Co.
    Buy
    May 20, 24 BTIG
    Buy
    Apr 29, 24 Piper Sandler
    Overweight
    Apr 29, 24 Guggenheim
    Buy
    Apr 11, 24 Morgan Stanley
    Equal-Weight
    Nov 14, 23 Morgan Stanley
    Equal-Weight

    Institutional Ownership

    Screeners with ABVX included

    Growing Shares Outstanding
    Stocks with high beta
    Best performing stocks last month
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotechnology industry
    • What is the ticker symbol for ABIVAX SA?
    • Does ABIVAX SA pay dividends?
    • What sector is ABIVAX SA in?
    • What industry is ABIVAX SA in?
    • What country is ABIVAX SA based in?
    • When did ABIVAX SA go public?
    • Is ABIVAX SA in the S&P 500?
    • Is ABIVAX SA in the NASDAQ 100?
    • Is ABIVAX SA in the Dow Jones?
    • When was ABIVAX SA's last earnings report?
    • When does ABIVAX SA report earnings?

    What is the ticker symbol for ABIVAX SA?

    The ticker symbol for ABIVAX SA is NASDAQ:ABVX

    Does ABIVAX SA pay dividends?

    No, ABIVAX SA does not pay dividends

    What sector is ABIVAX SA in?

    ABIVAX SA is in the Healthcare sector

    What industry is ABIVAX SA in?

    ABIVAX SA is in the Biotechnology industry

    What country is ABIVAX SA based in?

    ABIVAX SA is headquartered in France

    When did ABIVAX SA go public?

    ABIVAX SA's initial public offering (IPO) was on October 20, 2023

    Is ABIVAX SA in the S&P 500?

    No, ABIVAX SA is not included in the S&P 500 index

    Is ABIVAX SA in the NASDAQ 100?

    No, ABIVAX SA is not included in the NASDAQ 100 index

    Is ABIVAX SA in the Dow Jones?

    No, ABIVAX SA is not included in the Dow Jones index

    When was ABIVAX SA's last earnings report?

    ABIVAX SA's most recent earnings report was on Jun 2, 2025

    When does ABIVAX SA report earnings?

    The next expected earnings date for ABIVAX SA is Aug 11, 2025
    On this page